Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
German Primate Center · University of Göttingen · +5 more institutions
Indexed incrossrefpubmed
Abstract
Funder: \n Bundesministerium für Bildung und Forschung\n https://doi.org/10.13039/501100002347
Citation impact
517
total citations
- FWCI
- 12.12
- Percentile
- 100%
- References
- 14
Citations per year
Authors
6- MHMarkus HoffmannCorresponding
German Primate Center, University of Göttingen
- SSSimon Schroeder
Humboldt-Universität zu Berlin, German Center for Infection Research, Freie Universität Berlin, Charité - Universitätsmedizin Berlin
- HKHannah Kleine‐Weber
German Primate Center, University of Göttingen
- MAMarcel A. Müller
Sechenov University, Humboldt-Universität zu Berlin, German Center for Infection Research, Freie Universität Berlin, Charité - Universitätsmedizin Berlin
- CDChristian Drosten
Humboldt-Universität zu Berlin, German Center for Infection Research, Freie Universität Berlin, Charité - Universitätsmedizin Berlin
Topics & keywords
Topics
Keywords
- TMPRSS2
- Coronavirus
- Virology
- Middle East respiratory syndrome
- Serine protease
- Biology
- Betacoronavirus
- Pandemic
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.